chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: stiff neck; stiff back; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck) and MUSCULOSKELETAL STIFFNESS (stiff back) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included HYDROCODONE BITARTRATE, PARACETAMOL (NORCO), DILTIAZEM HCL, GLUCOSAMINE, GLIMEPIRIDE, HYDROCHLOROTHIAZIDE, LISINOPRIL, MECLIZINE HCL, METFORMIN, PRAVASTATIN SODIUM, SALBUTAMOL SULFATE (PROAIR HFA), SULFAMETHOXAZOLE, ASCORBIC ACID (VITAMIN C), VITAMIN D3, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), INSULIN GLARGINE (LANTUS), METOPROLOL and MIRABEGRON (MYRBETRIQ) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck) and MUSCULOSKELETAL STIFFNESS (stiff back). At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff neck) and MUSCULOSKELETAL STIFFNESS (stiff back) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant included accucheck was noted. Treatment included heating pad, Norco were provided by the reporter; Sender's Comments: Based on the current available information which includes a temporal association between the use of mRNA-1273 and the start date of the reported events, a causal relationship with the event cannot be excluded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Bed rest, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Laid up for about 36 hours; Itchy at the site of the injection; Red rash at the site of the injection; Red rash at the site of the injection; This spontaneous case was reported by a consumer and describes the occurrence of BED REST (Laid up for about 36 hours), VACCINATION SITE PRURITUS (Itchy at the site of the injection), VACCINATION SITE ERYTHEMA (Red rash at the site of the injection) and VACCINATION SITE RASH (Red rash at the site of the injection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BED REST (Laid up for about 36 hours), VACCINATION SITE PRURITUS (Itchy at the site of the injection), VACCINATION SITE ERYTHEMA (Red rash at the site of the injection) and VACCINATION SITE RASH (Red rash at the site of the injection). The patient was treated with CORTISONE at an unspecified dose and frequency. At the time of the report, BED REST (Laid up for about 36 hours), VACCINATION SITE PRURITUS (Itchy at the site of the injection), VACCINATION SITE ERYTHEMA (Red rash at the site of the injection) and VACCINATION SITE RASH (Red rash at the site of the injection) was resolving.            Concomitant product use was not provided by the reporter. Treatment for events included antihistamines.   This case was linked to MOD21-054285, MOD-2021-045004 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Non-significant follow up received and contains information about husband's case
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Migraine, Vaccination site pruritus
Clinical narrative: Had 2 severe migraines since the Moderna vaccine dose; Felt tired; Itchy at injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MIGRAINE (Had 2 severe migraines since the Moderna vaccine dose), FATIGUE (Felt tired) and VACCINATION SITE PRURITUS (Itchy at injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced FATIGUE (Felt tired) and VACCINATION SITE PRURITUS (Itchy at injection site). On 24-Mar-2021, the patient experienced MIGRAINE (Had 2 severe migraines since the Moderna vaccine dose). On 25-Mar-2021, MIGRAINE (Had 2 severe migraines since the Moderna vaccine dose) had resolved. At the time of the report, FATIGUE (Felt tired) and VACCINATION SITE PRURITUS (Itchy at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   patient received treatment with Tylenol twice and Maxalt twice for her migraine.   This case was linked to MOD21-063235 (E2B Linked Report).; Sender's Comments:  MOD21-063235:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Eye colour change
Clinical narrative: both eyes iris changed the color from blue to green; This spontaneous case was reported by a consumer and describes the occurrence of EYE COLOUR CHANGE (both eyes iris changed the color from blue to green) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced EYE COLOUR CHANGE (both eyes iris changed the color from blue to green). At the time of the report, EYE COLOUR CHANGE (both eyes iris changed the color from blue to green) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications was not provided.; Sender's Comments: Based on the current available information which includes a temporal association between the use of mRNA-1273 and the start date of the reported events, a causal relationship with the event cannot be excluded
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (tired). At the time of the report, FATIGUE (tired) had resolved.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site erythema, Vaccination site pain
Clinical narrative: Injection site is greenish at the top and reddish around it; Injection site is reddish; Injection site is sore to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Injection site is greenish at the top and reddish around it) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Injection site is greenish at the top and reddish around it). At the time of the report, VACCINATION SITE DISCOLOURATION (Injection site is greenish at the top and reddish around it) outcome was unknown.            Treatment medication included use of Amica cream to alleviate the symptoms.; Sender's Comments: Based on the current available information which includes a temporal association between the use of mRNA-1273 and the start date of the reported events, a causal relationship with the event cannot be excluded. Vaccination site pain  and vaccination site erythema are consistent with the known safety profile of the vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: pain in arm; Pain moving to other arm and legs (groin/lower back/right hip; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in arm) and PAIN (Pain moving to other arm and legs (groin/lower back/right hip) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain in arm) and PAIN (Pain moving to other arm and legs (groin/lower back/right hip). At the time of the report, VACCINATION SITE PAIN (pain in arm) and PAIN (Pain moving to other arm and legs (groin/lower back/right hip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient was on breast cancer medication. The treatment taken included acetaminophen, aspirin and ibuprofen.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of lymphadenopathy (he experienced swelling of lymph nodes in left arm) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# undisclosed) for COVID-19 immunization. The patient's past medical history included no adverse event. On Mar 25, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced lymphadenopathy (he experienced swelling of lymph nodes in left arm). At the time of the report, lymphadenopathy (he experienced swelling of lymph nodes in left arm) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Palpitations
Clinical narrative: Dizzy; heart palpitation; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) and PALPITATIONS (heart palpitation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 13A2A) for COVID-19 vaccination.     Concurrent medical conditions included Hyperthyroidism.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced DIZZINESS (Dizzy) and PALPITATIONS (heart palpitation). On 02-Mar-2021, DIZZINESS (Dizzy) and PALPITATIONS (heart palpitation) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment Medication was available. No Concomitant Medication was available.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Lymphadenopathy, Myalgia
Clinical narrative: Swollen lymph node; Just above my right clavicle was swollen; Sweats; Headache; A low grade temp; Chills; Muscle pains; This spontaneous case was reported by a nurse and describes the occurrence of SWELLING (Just above my right clavicle was swollen), HYPERHIDROSIS (Sweats), LYMPHADENOPATHY (Swollen lymph node), HEADACHE (Headache) and PYREXIA (A low grade temp) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced HYPERHIDROSIS (Sweats), HEADACHE (Headache), PYREXIA (A low grade temp), CHILLS (Chills) and MYALGIA (Muscle pains). On 18-Feb-2021, the patient experienced SWELLING (Just above my right clavicle was swollen) and LYMPHADENOPATHY (Swollen lymph node). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, SWELLING (Just above my right clavicle was swollen), HYPERHIDROSIS (Sweats), LYMPHADENOPATHY (Swollen lymph node), HEADACHE (Headache), PYREXIA (A low grade temp), CHILLS (Chills) and MYALGIA (Muscle pains) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-016832 (Patient Link).
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling
Clinical narrative: Swollen lymph node; Just above my right clavicle was swollen; Sweats; Headache; A low grade temp; Chills; Muscle pains; This spontaneous case was reported by a nurse and describes the occurrence of SWELLING (Just above my right clavicle was swollen), HYPERHIDROSIS (Sweats), LYMPHADENOPATHY (Swollen lymph node), HEADACHE (Headache) and PYREXIA (A low grade temp) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Feb-2021, the patient experienced HYPERHIDROSIS (Sweats), HEADACHE (Headache), PYREXIA (A low grade temp), CHILLS (Chills) and MYALGIA (Muscle pains). On 18-Feb-2021, the patient experienced SWELLING (Just above my right clavicle was swollen) and LYMPHADENOPATHY (Swollen lymph node). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, SWELLING (Just above my right clavicle was swollen), HYPERHIDROSIS (Sweats), LYMPHADENOPATHY (Swollen lymph node), HEADACHE (Headache), PYREXIA (A low grade temp), CHILLS (Chills) and MYALGIA (Muscle pains) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-016832 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Condition aggravated, Gait disturbance, Headache, Hyperhidrosis
Clinical narrative: and unable to get up off of the bed or couch; panic attacks; heart palpitations; higher anxiety amped up and worry; shaking; drenched in pool of sweating; headache became worse, day symptoms got worse and worse; low grade fever; slight headache; feeling achy; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (higher anxiety amped up and worry), HYPERHIDROSIS (drenched in pool of sweating), CONDITION AGGRAVATED (headache became worse, day symptoms got worse and worse), GAIT DISTURBANCE (and unable to get up off of the bed or couch) and PANIC ATTACK (panic attacks) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety (Anxiety). Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 11-Mar-2021, the patient experienced PAIN (feeling achy). 11-Mar-2021, the patient experienced PYREXIA (low grade fever) and HEADACHE (slight headache). On 12-Mar-2021, the patient experienced CONDITION AGGRAVATED (headache became worse, day symptoms got worse and worse). On 13-Mar-2021, the patient experienced HYPERHIDROSIS (drenched in pool of sweating). On an unknown date, the patient experienced ANXIETY (higher anxiety amped up and worry), GAIT DISTURBANCE (and unable to get up off of the bed or couch), PANIC ATTACK (panic attacks), PALPITATIONS (heart palpitations) and TREMOR (shaking). The patient was treated with ALPRAZOLAM for Symptomatic treatment, at an unspecified dose and frequency and SERTRALINE ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, ANXIETY (higher anxiety amped up and worry), HYPERHIDROSIS (drenched in pool of sweating), CONDITION AGGRAVATED (headache became worse, day symptoms got worse and worse), GAIT DISTURBANCE (and unable to get up off of the bed or couch), PANIC ATTACK (panic attacks), PALPITATIONS (heart palpitations), PAIN (feeling achy), TREMOR (shaking), PYREXIA (low grade fever) and HEADACHE (slight headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Palpitations, Panic attack, Pyrexia, Tremor
Clinical narrative: and unable to get up off of the bed or couch; panic attacks; heart palpitations; higher anxiety amped up and worry; shaking; drenched in pool of sweating; headache became worse, day symptoms got worse and worse; low grade fever; slight headache; feeling achy; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (higher anxiety amped up and worry), HYPERHIDROSIS (drenched in pool of sweating), CONDITION AGGRAVATED (headache became worse, day symptoms got worse and worse), GAIT DISTURBANCE (and unable to get up off of the bed or couch) and PANIC ATTACK (panic attacks) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety (Anxiety). Concomitant products included VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 11-Mar-2021, the patient experienced PAIN (feeling achy). 11-Mar-2021, the patient experienced PYREXIA (low grade fever) and HEADACHE (slight headache). On 12-Mar-2021, the patient experienced CONDITION AGGRAVATED (headache became worse, day symptoms got worse and worse). On 13-Mar-2021, the patient experienced HYPERHIDROSIS (drenched in pool of sweating). On an unknown date, the patient experienced ANXIETY (higher anxiety amped up and worry), GAIT DISTURBANCE (and unable to get up off of the bed or couch), PANIC ATTACK (panic attacks), PALPITATIONS (heart palpitations) and TREMOR (shaking). The patient was treated with ALPRAZOLAM for Symptomatic treatment, at an unspecified dose and frequency and SERTRALINE ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, ANXIETY (higher anxiety amped up and worry), HYPERHIDROSIS (drenched in pool of sweating), CONDITION AGGRAVATED (headache became worse, day symptoms got worse and worse), GAIT DISTURBANCE (and unable to get up off of the bed or couch), PANIC ATTACK (panic attacks), PALPITATIONS (heart palpitations), PAIN (feeling achy), TREMOR (shaking), PYREXIA (low grade fever) and HEADACHE (slight headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Fever; Tiredness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), FATIGUE (Tiredness) and HEADACHE (Headache) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced PYREXIA (Fever), FATIGUE (Tiredness) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), FATIGUE (Tiredness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: welts, looks like mosquito bites; skin rash on legs and buttocks; This spontaneous case was reported by a patient and describes the occurrence of URTICARIA (welts, looks like mosquito bites) and RASH (skin rash on legs and buttocks) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), METHENAMINE HIPPURATE and HYDROCHLOROTHIAZIDE for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced URTICARIA (welts, looks like mosquito bites) and RASH (skin rash on legs and buttocks). On 14-Mar-2021, URTICARIA (welts, looks like mosquito bites) and RASH (skin rash on legs and buttocks) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient's Teladoc prescribed Hydroxyzine, Benadryl, Triamcinolone ointment as treatment and symptoms resolved the following day.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests, Balance disorder, Body temperature, Chest pain, Feeling abnormal
Clinical narrative: sensitivity to high-pitched sounds; vertigo; ringing in ears. It is mostly to right ear; temperature was 99F; shaking so much; not having control of my body; chest pain; icky; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking so much), BALANCE DISORDER (not having control of my body), CHEST PAIN (chest pain), FEELING ABNORMAL (icky) and VERTIGO (vertigo) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced TREMOR (shaking so much), BALANCE DISORDER (not having control of my body), CHEST PAIN (chest pain), FEELING ABNORMAL (icky) and PYREXIA (temperature was 99F). On 18-Mar-2021, the patient experienced VERTIGO (vertigo) and TINNITUS (ringing in ears. It is mostly to right ear). On an unknown date, the patient experienced HYPERACUSIS (sensitivity to high-pitched sounds). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 17-Mar-2021, TREMOR (shaking so much), BALANCE DISORDER (not having control of my body), CHEST PAIN (chest pain) and FEELING ABNORMAL (icky) outcome was unknown. On 19-Mar-2021, VERTIGO (vertigo) outcome was unknown. At the time of the report, TINNITUS (ringing in ears. It is mostly to right ear), HYPERACUSIS (sensitivity to high-pitched sounds) and PYREXIA (temperature was 99F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Body temperature: 99 (High) High. On an unknown date, Acoustic stimulation tests: normal (normal) normal. On an unknown date, Tinnitus: normal (normal) normal.         No concomitant medications were reported.    This case was linked to MOD21-063201, MOD21-063202 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperacusis, Pyrexia, Tinnitus, Tremor, Vertigo
Clinical narrative: sensitivity to high-pitched sounds; vertigo; ringing in ears. It is mostly to right ear; temperature was 99F; shaking so much; not having control of my body; chest pain; icky; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shaking so much), BALANCE DISORDER (not having control of my body), CHEST PAIN (chest pain), FEELING ABNORMAL (icky) and VERTIGO (vertigo) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced TREMOR (shaking so much), BALANCE DISORDER (not having control of my body), CHEST PAIN (chest pain), FEELING ABNORMAL (icky) and PYREXIA (temperature was 99F). On 18-Mar-2021, the patient experienced VERTIGO (vertigo) and TINNITUS (ringing in ears. It is mostly to right ear). On an unknown date, the patient experienced HYPERACUSIS (sensitivity to high-pitched sounds). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 17-Mar-2021, TREMOR (shaking so much), BALANCE DISORDER (not having control of my body), CHEST PAIN (chest pain) and FEELING ABNORMAL (icky) outcome was unknown. On 19-Mar-2021, VERTIGO (vertigo) outcome was unknown. At the time of the report, TINNITUS (ringing in ears. It is mostly to right ear), HYPERACUSIS (sensitivity to high-pitched sounds) and PYREXIA (temperature was 99F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Body temperature: 99 (High) High. On an unknown date, Acoustic stimulation tests: normal (normal) normal. On an unknown date, Tinnitus: normal (normal) normal.         No concomitant medications were reported.    This case was linked to MOD21-063201, MOD21-063202 (Patient Link).
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Disturbance in attention, Dizziness, Feeling abnormal, Feeling hot, Nervousness
Clinical narrative: Thinking is not straight forward; Dizziness in head; Nervous; Heart palpitations; Got a bad feeling after first shot; "inward heat" feeling; Sensation that she has "lead" and it affects her focus; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Got a bad feeling after first shot), FEELING HOT ("inward heat" feeling), DISTURBANCE IN ATTENTION (Sensation that she has "lead" and it affects her focus), THINKING ABNORMAL (Thinking is not straight forward) and DIZZINESS (Dizziness in head) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Got a bad feeling after first shot), FEELING HOT ("inward heat" feeling), DISTURBANCE IN ATTENTION (Sensation that she has "lead" and it affects her focus), THINKING ABNORMAL (Thinking is not straight forward), DIZZINESS (Dizziness in head), NERVOUSNESS (Nervous) and PALPITATIONS (Heart palpitations). At the time of the report, FEELING ABNORMAL (Got a bad feeling after first shot), FEELING HOT ("inward heat" feeling), DISTURBANCE IN ATTENTION (Sensation that she has "lead" and it affects her focus), THINKING ABNORMAL (Thinking is not straight forward), DIZZINESS (Dizziness in head), NERVOUSNESS (Nervous) and PALPITATIONS (Heart palpitations) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Thinking abnormal
Clinical narrative: Thinking is not straight forward; Dizziness in head; Nervous; Heart palpitations; Got a bad feeling after first shot; "inward heat" feeling; Sensation that she has "lead" and it affects her focus; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Got a bad feeling after first shot), FEELING HOT ("inward heat" feeling), DISTURBANCE IN ATTENTION (Sensation that she has "lead" and it affects her focus), THINKING ABNORMAL (Thinking is not straight forward) and DIZZINESS (Dizziness in head) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Got a bad feeling after first shot), FEELING HOT ("inward heat" feeling), DISTURBANCE IN ATTENTION (Sensation that she has "lead" and it affects her focus), THINKING ABNORMAL (Thinking is not straight forward), DIZZINESS (Dizziness in head), NERVOUSNESS (Nervous) and PALPITATIONS (Heart palpitations). At the time of the report, FEELING ABNORMAL (Got a bad feeling after first shot), FEELING HOT ("inward heat" feeling), DISTURBANCE IN ATTENTION (Sensation that she has "lead" and it affects her focus), THINKING ABNORMAL (Thinking is not straight forward), DIZZINESS (Dizziness in head), NERVOUSNESS (Nervous) and PALPITATIONS (Heart palpitations) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.
Sex: M
Vaccine: COVID19
Symptoms: Skin lesion, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: vaccination site reaction; skin lesion; Vaccination site pruritus; Vaccination site erythema; Vaccination site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (vaccination site reaction), SKIN LESION (skin lesion), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PAIN (Vaccination site tenderness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (vaccination site reaction), SKIN LESION (skin lesion), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PAIN (Vaccination site tenderness). At the time of the report, VACCINATION SITE REACTION (vaccination site reaction), SKIN LESION (skin lesion), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PAIN (Vaccination site tenderness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication were provided. No concomitant medication were provided.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Red rash on her upper arm; This spontaneous case was reported by a patient and describes the occurrence of RASH ERYTHEMATOUS (Red rash on her upper arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH ERYTHEMATOUS (Red rash on her upper arm). At the time of the report, RASH ERYTHEMATOUS (Red rash on her upper arm) had resolved. Not Provided          No relevant concomitant medications were reported. The patient did not take any treatment medication for the event. The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Additional information was received on 11-May-2021.address updated
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Insomnia
Clinical narrative: Insomnia; Felt tired; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Insomnia), FATIGUE (Felt tired), HEADACHE (Headache) and CHILLS (Chills) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced INSOMNIA (Insomnia), FATIGUE (Felt tired), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, INSOMNIA (Insomnia), FATIGUE (Felt tired), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue
Clinical narrative: Queasy stomach; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Queasy stomach) and FATIGUE (Tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Queasy stomach) and FATIGUE (Tiredness). At the time of the report, ABDOMINAL DISCOMFORT (Queasy stomach) and FATIGUE (Tiredness) outcome was unknown.            no concomitant and treatment product was reported The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments   This case was linked to MOD-2021-038171 (Patient Link).
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Feeling cold, Headache
Clinical narrative: I was dizzy and I thought I was going to faint; Temperature was 100 degrees; Headache; Muscle pain; Joint pain; Nausea; She was so cold; Pain at the injection site; chills; Arm was swollen and puffy; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen and puffy), DIZZINESS (I was dizzy and I thought I was going to faint), FEELING COLD (She was so cold), VACCINATION SITE PAIN (Pain at the injection site) and CHILLS (chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0011A21A and 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 25-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen and puffy), FEELING COLD (She was so cold), VACCINATION SITE PAIN (Pain at the injection site) and CHILLS (chills). On 26-Mar-2021, the patient experienced DIZZINESS (I was dizzy and I thought I was going to faint), PYREXIA (Temperature was 100 degrees), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (Nausea). At the time of the report, PERIPHERAL SWELLING (Arm was swollen and puffy), DIZZINESS (I was dizzy and I thought I was going to faint), FEELING COLD (She was so cold), VACCINATION SITE PAIN (Pain at the injection site), CHILLS (chills), PYREXIA (Temperature was 100 degrees), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (Nausea) outcome was unknown.            Concomitant medications were not reported. Treatment information were not provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Peripheral swelling, Pyrexia, Vaccination site pain
Clinical narrative: I was dizzy and I thought I was going to faint; Temperature was 100 degrees; Headache; Muscle pain; Joint pain; Nausea; She was so cold; Pain at the injection site; chills; Arm was swollen and puffy; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm was swollen and puffy), DIZZINESS (I was dizzy and I thought I was going to faint), FEELING COLD (She was so cold), VACCINATION SITE PAIN (Pain at the injection site) and CHILLS (chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0011A21A and 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 25-Mar-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen and puffy), FEELING COLD (She was so cold), VACCINATION SITE PAIN (Pain at the injection site) and CHILLS (chills). On 26-Mar-2021, the patient experienced DIZZINESS (I was dizzy and I thought I was going to faint), PYREXIA (Temperature was 100 degrees), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (Nausea). At the time of the report, PERIPHERAL SWELLING (Arm was swollen and puffy), DIZZINESS (I was dizzy and I thought I was going to faint), FEELING COLD (She was so cold), VACCINATION SITE PAIN (Pain at the injection site), CHILLS (chills), PYREXIA (Temperature was 100 degrees), HEADACHE (Headache), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and NAUSEA (Nausea) outcome was unknown.            Concomitant medications were not reported. Treatment information were not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Very tired; Bad sweats; Feeling bad; Blood pressure was 146/74 mmHg/ that same morning blood pressure was even higher 152/80 mmHg and in the afternoon was 159/80; Arm was teriibly sore; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Blood pressure was 146/74 mmHg/ that same morning blood pressure was even higher 152/80 mmHg and in the afternoon was 159/80), HYPERHIDROSIS (Bad sweats), PAIN IN EXTREMITY (Arm was teriibly sore), FEELING ABNORMAL (Feeling bad) and FATIGUE (Very tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was teriibly sore). On 06-Mar-2021, the patient experienced BLOOD PRESSURE INCREASED (Blood pressure was 146/74 mmHg/ that same morning blood pressure was even higher 152/80 mmHg and in the afternoon was 159/80). On 09-Mar-2021, the patient experienced HYPERHIDROSIS (Bad sweats) and FEELING ABNORMAL (Feeling bad). On 11-Mar-2021, the patient experienced FATIGUE (Very tired). The patient was treated with AMLODIPINE for Blood pressure, at a dose of 1 dosage form; AMLODIPINE for Blood pressure, at a dose of 1 dosage form; ROSUVASTATIN CALCIUM (CRESTOR) at an unspecified dose and frequency and METOPROLOL at an unspecified dose and frequency. On 09-Mar-2021, BLOOD PRESSURE INCREASED (Blood pressure was 146/74 mmHg/ that same morning blood pressure was even higher 152/80 mmHg and in the afternoon was 159/80) had resolved. At the time of the report, HYPERHIDROSIS (Bad sweats) had not resolved and PAIN IN EXTREMITY (Arm was teriibly sore), FEELING ABNORMAL (Feeling bad) and FATIGUE (Very tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, Blood pressure measurement: 130/74 mmHg (High) 130/74 mmHg (normal for patient is 120/71 mmHg). On 06-Mar-2021, Blood pressure measurement: 131/68 mmHg (High) 131/68 mmHg. On 07-Mar-2021, Blood pressure measurement: 131/68 mmHg (High) 131/68 mmHg. On 08-Mar-2021, Blood pressure measurement: 131/68 mmHg (High) 131/68 mmHg. On 09-Mar-2021, Blood pressure measurement: 146/74 mmHg (High) early morning, 152/80 mmHg (High) that same morning was even higher and 159/80 mmHg (High) in afternoon.         Concomitant product use was not provided by the reporter.  The patient had bad sweats which occurred again on 10-Mar-2021.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-041707 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-041707:Same patient: 1st Dose
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Contusion, Skin discolouration
Clinical narrative: bruising yellowish spot on opposite left arm and two bruising fingers on left arm; bruising fingers on left arm; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (bruising yellowish spot on opposite left arm and two bruising fingers on left arm) and CONTUSION (bruising fingers on left arm) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included Immune thrombocytopenia. Concomitant products included LOSARTAN, SIMVASTATIN and STEROIDS for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced SKIN DISCOLOURATION (bruising yellowish spot on opposite left arm and two bruising fingers on left arm) and CONTUSION (bruising fingers on left arm). At the time of the report, SKIN DISCOLOURATION (bruising yellowish spot on opposite left arm and two bruising fingers on left arm) and CONTUSION (bruising fingers on left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information related to the events was not provided